Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.
The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium
The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors
The company has strong R&D capabilities with in-house labs and pilot-scale facilities focused on mineral salts and excipients.
Product Portfolio:
As of December 31, 2024, the company had 704 permanent employees.
Competitve Strengths:
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 50% | 5282463 crores |
| Non-Institutional Investors (NIIs | 15% | 1584738.9 crores |
| Retail Individual Investors (RIIs) | 35% | 3697724.1 crores |
| Allotment Date | Listing Date |
|---|---|
| 26 Nov '25 | 28 Nov '25 |
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Sudeep Pharma Ltd ipo has been designed to ensure broad participation while maintaining optimal price discovery.